aluates Reports

$ 0.0

Automative

Global Castration Resistant Prostate Cancer Treatment Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-4O6381

Global Castration Resistant Prostate Cancer Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Global Castration Resistant Prostate Cancer Treatment Market Research Report 2025

Code: QYRE-Auto-4O6381

Report

September 2025

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Active Biotech

Diagnocure

GlaxoSmithKline PLC

Northwest Biotherapeutics

Millennium Pharmaceuticals

Hologic Inc

Spectrum Pharmaceuticals

Abbott Laboratories

Bayer HealthCare Pharmaceuticals

Castration Resistant Prostate Cancer Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Castration Resistant Prostate Cancer Treatment Market

The global market for Castration Resistant Prostate Cancer Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Prostate cancer can be defined as it is a form of cancer that develops into male reproductive system. Most of the prostate cancer are slow growing and stable but sometimes it can spread from prostate (gland) to other part of body such as bone and lymph node. Initially prostate cancer does not pose any symptom but in severe cases it can cause pain during urination and can cause problem during sexual intercourse. Castration resistant prostate cancer is referred to as a prostate cancer that is spread to other parts of body and is resistant to medical or surgical treatment. Risk factor for castration resistant prostate cancer includes genetic predisposition, geriatric population, unhygienic diet, medication exposure and many sexual partners. Diagnosis for the detection of castration resistant prostate cancer includes prostate imaging, biopsy, tumor marker and staging test. Crucial factor about castration resistant prostate cancer is that it is resistant to medical and surgical treatment. However, other treatment options that are available in the market include hormone therapy, immune modulation, antiangiogenic treatment and bone targeted therapies.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Castration Resistant Prostate Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Castration Resistant Prostate Cancer Treatment.

The Castration Resistant Prostate Cancer Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Castration Resistant Prostate Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Castration Resistant Prostate Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Castration Resistant Prostate Cancer Treatment Market Report

Report Metric	Details
Report Name	Castration Resistant Prostate Cancer Treatment Market
CAGR	5%
Segment by Type	Hormonal Therapy Adding An Anti-Androgen Stopping An Anti-Androgen Estrogens Chemotherapy Radiation Therapy Others
Segment by Application	Hospital Ambulatory Surgical Centers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Active Biotech, Diagnocure, Glaxosmithkline, Northwest Biotherapeutics, Millennium Pharmaceuticals, Hologic, Spectrum Pharmaceuticals, Abbott Laboratories, Bayer Healthcare Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Castration Resistant Prostate Cancer Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Castration Resistant Prostate Cancer Treatment Market report?

Ans: The main players in the Castration Resistant Prostate Cancer Treatment Market are Active Biotech, Diagnocure, Glaxosmithkline, Northwest Biotherapeutics, Millennium Pharmaceuticals, Hologic, Spectrum Pharmaceuticals, Abbott Laboratories, Bayer Healthcare Pharmaceuticals

What are the Application segmentation covered in the Castration Resistant Prostate Cancer Treatment Market report?

Ans: The Applications covered in the Castration Resistant Prostate Cancer Treatment Market report are Hospital, Ambulatory Surgical Centers

What are the Type segmentation covered in the Castration Resistant Prostate Cancer Treatment Market report?

Ans: The Types covered in the Castration Resistant Prostate Cancer Treatment Market report are Hormonal Therapy, Adding An Anti-Androgen, Stopping An Anti-Androgen, Estrogens, Chemotherapy, Radiation Therapy, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Hormonal Therapy

1.2.3 Adding An Anti-Androgen

1.2.4 Stopping An Anti-Androgen

1.2.5 Estrogens

1.2.6 Chemotherapy

1.2.7 Radiation Therapy

1.2.8 Others

1.3 Market by Application

1.3.1 Global Castration Resistant Prostate Cancer Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Ambulatory Surgical Centers

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Castration Resistant Prostate Cancer Treatment Market Perspective (2020-2031)

2.2 Global Castration Resistant Prostate Cancer Treatment Growth Trends by Region

2.2.1 Global Castration Resistant Prostate Cancer Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Castration Resistant Prostate Cancer Treatment Historic Market Size by Region (2020-2025)

2.2.3 Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Region (2026-2031)

2.3 Castration Resistant Prostate Cancer Treatment Market Dynamics

2.3.1 Castration Resistant Prostate Cancer Treatment Industry Trends

2.3.2 Castration Resistant Prostate Cancer Treatment Market Drivers

2.3.3 Castration Resistant Prostate Cancer Treatment Market Challenges

2.3.4 Castration Resistant Prostate Cancer Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Castration Resistant Prostate Cancer Treatment Players by Revenue

3.1.1 Global Top Castration Resistant Prostate Cancer Treatment Players by Revenue (2020-2025)

3.1.2 Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Castration Resistant Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Castration Resistant Prostate Cancer Treatment Revenue

3.4 Global Castration Resistant Prostate Cancer Treatment Market Concentration Ratio

3.4.1 Global Castration Resistant Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Castration Resistant Prostate Cancer Treatment Revenue in 2024

3.5 Global Key Players of Castration Resistant Prostate Cancer Treatment Head office and Area Served

3.6 Global Key Players of Castration Resistant Prostate Cancer Treatment, Product and Application

3.7 Global Key Players of Castration Resistant Prostate Cancer Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Castration Resistant Prostate Cancer Treatment Breakdown Data by Type

4.1 Global Castration Resistant Prostate Cancer Treatment Historic Market Size by Type (2020-2025)

4.2 Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Type (2026-2031)

5 Castration Resistant Prostate Cancer Treatment Breakdown Data by Application

5.1 Global Castration Resistant Prostate Cancer Treatment Historic Market Size by Application (2020-2025)

5.2 Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Castration Resistant Prostate Cancer Treatment Market Size (2020-2031)

6.2 North America Castration Resistant Prostate Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2020-2025)

6.4 North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Castration Resistant Prostate Cancer Treatment Market Size (2020-2031)

7.2 Europe Castration Resistant Prostate Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2020-2025)

7.4 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size (2020-2031)

8.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size (2020-2031)

9.2 Latin America Castration Resistant Prostate Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2020-2025)

9.4 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size (2020-2031)

10.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Active Biotech

11.1.1 Active Biotech Company Details

11.1.2 Active Biotech Business Overview

11.1.3 Active Biotech Castration Resistant Prostate Cancer Treatment Introduction

11.1.4 Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

11.1.5 Active Biotech Recent Development

11.2 Diagnocure

11.2.1 Diagnocure Company Details

11.2.2 Diagnocure Business Overview

11.2.3 Diagnocure Castration Resistant Prostate Cancer Treatment Introduction

11.2.4 Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

11.2.5 Diagnocure Recent Development

11.3 Glaxosmithkline

11.3.1 Glaxosmithkline Company Details

11.3.2 Glaxosmithkline Business Overview

11.3.3 Glaxosmithkline Castration Resistant Prostate Cancer Treatment Introduction

11.3.4 Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

11.3.5 Glaxosmithkline Recent Development

11.4 Northwest Biotherapeutics

11.4.1 Northwest Biotherapeutics Company Details

11.4.2 Northwest Biotherapeutics Business Overview

11.4.3 Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Introduction

11.4.4 Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

11.4.5 Northwest Biotherapeutics Recent Development

11.5 Millennium Pharmaceuticals

11.5.1 Millennium Pharmaceuticals Company Details

11.5.2 Millennium Pharmaceuticals Business Overview

11.5.3 Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction

11.5.4 Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

11.5.5 Millennium Pharmaceuticals Recent Development

11.6 Hologic

11.6.1 Hologic Company Details

11.6.2 Hologic Business Overview

11.6.3 Hologic Castration Resistant Prostate Cancer Treatment Introduction

11.6.4 Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

11.6.5 Hologic Recent Development

11.7 Spectrum Pharmaceuticals

11.7.1 Spectrum Pharmaceuticals Company Details

11.7.2 Spectrum Pharmaceuticals Business Overview

11.7.3 Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction

11.7.4 Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

11.7.5 Spectrum Pharmaceuticals Recent Development

11.8 Abbott Laboratories

11.8.1 Abbott Laboratories Company Details

11.8.2 Abbott Laboratories Business Overview

11.8.3 Abbott Laboratories Castration Resistant Prostate Cancer Treatment Introduction

11.8.4 Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

11.8.5 Abbott Laboratories Recent Development

11.9 Bayer Healthcare Pharmaceuticals

11.9.1 Bayer Healthcare Pharmaceuticals Company Details

11.9.2 Bayer Healthcare Pharmaceuticals Business Overview

11.9.3 Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction

11.9.4 Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

11.9.5 Bayer Healthcare Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Active Biotech

Diagnocure

GlaxoSmithKline PLC

Northwest Biotherapeutics

Millennium Pharmaceuticals

Hologic Inc

Spectrum Pharmaceuticals

Abbott Laboratories

Bayer HealthCare Pharmaceuticals

List of Tables

Table 1. Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Hormonal Therapy

Table 3. Key Players of Adding An Anti-Androgen

Table 4. Key Players of Stopping An Anti-Androgen

Table 5. Key Players of Estrogens

Table 6. Key Players of Chemotherapy

Table 7. Key Players of Radiation Therapy

Table 8. Key Players of Others

Table 9. Global Castration Resistant Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Castration Resistant Prostate Cancer Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Castration Resistant Prostate Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Castration Resistant Prostate Cancer Treatment Market Share by Region (2020-2025)

Table 13. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Castration Resistant Prostate Cancer Treatment Market Share by Region (2026-2031)

Table 15. Castration Resistant Prostate Cancer Treatment Market Trends

Table 16. Castration Resistant Prostate Cancer Treatment Market Drivers

Table 17. Castration Resistant Prostate Cancer Treatment Market Challenges

Table 18. Castration Resistant Prostate Cancer Treatment Market Restraints

Table 19. Global Castration Resistant Prostate Cancer Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Castration Resistant Prostate Cancer Treatment Market Share by Players (2020-2025)

Table 21. Global Top Castration Resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Castration Resistant Prostate Cancer Treatment as of 2024)

Table 22. Ranking of Global Top Castration Resistant Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Castration Resistant Prostate Cancer Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Castration Resistant Prostate Cancer Treatment, Headquarters and Area Served

Table 25. Global Key Players of Castration Resistant Prostate Cancer Treatment, Product and Application

Table 26. Global Key Players of Castration Resistant Prostate Cancer Treatment, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Castration Resistant Prostate Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2020-2025)

Table 30. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2026-2031)

Table 32. Global Castration Resistant Prostate Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Application (2020-2025)

Table 34. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Application (2026-2031)

Table 36. North America Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 51. Active Biotech Company Details

Table 52. Active Biotech Business Overview

Table 53. Active Biotech Castration Resistant Prostate Cancer Treatment Product

Table 54. Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 55. Active Biotech Recent Development

Table 56. Diagnocure Company Details

Table 57. Diagnocure Business Overview

Table 58. Diagnocure Castration Resistant Prostate Cancer Treatment Product

Table 59. Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 60. Diagnocure Recent Development

Table 61. Glaxosmithkline Company Details

Table 62. Glaxosmithkline Business Overview

Table 63. Glaxosmithkline Castration Resistant Prostate Cancer Treatment Product

Table 64. Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 65. Glaxosmithkline Recent Development

Table 66. Northwest Biotherapeutics Company Details

Table 67. Northwest Biotherapeutics Business Overview

Table 68. Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Product

Table 69. Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 70. Northwest Biotherapeutics Recent Development

Table 71. Millennium Pharmaceuticals Company Details

Table 72. Millennium Pharmaceuticals Business Overview

Table 73. Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product

Table 74. Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 75. Millennium Pharmaceuticals Recent Development

Table 76. Hologic Company Details

Table 77. Hologic Business Overview

Table 78. Hologic Castration Resistant Prostate Cancer Treatment Product

Table 79. Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 80. Hologic Recent Development

Table 81. Spectrum Pharmaceuticals Company Details

Table 82. Spectrum Pharmaceuticals Business Overview

Table 83. Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product

Table 84. Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 85. Spectrum Pharmaceuticals Recent Development

Table 86. Abbott Laboratories Company Details

Table 87. Abbott Laboratories Business Overview

Table 88. Abbott Laboratories Castration Resistant Prostate Cancer Treatment Product

Table 89. Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 90. Abbott Laboratories Recent Development

Table 91. Bayer Healthcare Pharmaceuticals Company Details

Table 92. Bayer Healthcare Pharmaceuticals Business Overview

Table 93. Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product

Table 94. Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 95. Bayer Healthcare Pharmaceuticals Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Castration Resistant Prostate Cancer Treatment Picture

Figure 2. Global Castration Resistant Prostate Cancer Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Castration Resistant Prostate Cancer Treatment Market Share by Type: 2024 VS 2031

Figure 4. Hormonal Therapy Features

Figure 5. Adding An Anti-Androgen Features

Figure 6. Stopping An Anti-Androgen Features

Figure 7. Estrogens Features

Figure 8. Chemotherapy Features

Figure 9. Radiation Therapy Features

Figure 10. Others Features

Figure 11. Global Castration Resistant Prostate Cancer Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Castration Resistant Prostate Cancer Treatment Market Share by Application: 2024 VS 2031

Figure 13. Hospital Case Studies

Figure 14. Ambulatory Surgical Centers Case Studies

Figure 15. Castration Resistant Prostate Cancer Treatment Report Years Considered

Figure 16. Global Castration Resistant Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Castration Resistant Prostate Cancer Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Castration Resistant Prostate Cancer Treatment Market Share by Region: 2024 VS 2031

Figure 19. Global Castration Resistant Prostate Cancer Treatment Market Share by Players in 2024

Figure 20. Global Top Castration Resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Castration Resistant Prostate Cancer Treatment as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Castration Resistant Prostate Cancer Treatment Revenue in 2024

Figure 22. North America Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Castration Resistant Prostate Cancer Treatment Market Share by Country (2020-2031)

Figure 24. United States Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Castration Resistant Prostate Cancer Treatment Market Share by Country (2020-2031)

Figure 28. Germany Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Share by Region (2020-2031)

Figure 36. China Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Castration Resistant Prostate Cancer Treatment Market Share by Country (2020-2031)

Figure 44. Mexico Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Share by Country (2020-2031)

Figure 48. Turkey Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Active Biotech Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

Figure 52. Diagnocure Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

Figure 53. Glaxosmithkline Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

Figure 54. Northwest Biotherapeutics Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

Figure 55. Millennium Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

Figure 56. Hologic Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

Figure 57. Spectrum Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

Figure 58. Abbott Laboratories Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

Figure 59. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Castration resistant Prostate Cancer Drugs Market Research Report 2025

Global Metastatic Prostate Cancer Treatment Market Research Report 2024

Global Castrate Resistant Prostate Cancer Therapeutics Market Research Report 2025

Castration Resistant Prostate Cancer CRPC HRPCA Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Medicine Market Insights Forecast to 2030

Global Prostate Cancer Diagnostics and Treatment Market Research Report 2025

Hormone Refractory Prostate Cancer HRPCA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Diagnosis and Therapy Market Research Report 2024

Minimally Invasive Prostate Cancer Surgery Market

Global Urological Cancer Drugs Market Research Report 2024

Global Urological Cancer Therapeutics Drugs Market Research Report 2024

Testicular Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prostate Cancer Minimally Invasive Surgery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Genitourinary Cancers Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Molecular Diagnostics Market Research Report 2024

Prostate Cancer Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Advanced Prostate Cancer Drug Market Research Report 2025

Global Prostate Cancer Market Insights Forecast to 2030

Global Prostate Cancer Devices Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions